Tabuk Pharmaceuticals Overview
Pro stress-test →Tabuk Pharmaceuticals, established in 1994 and headquartered in Riyadh, is the largest privately-owned pharmaceutical company in Saudi Arabia, with a strong market presence throughout the Middle East and North Africa (MENA) region. The company manufactures and distributes a wide range of pharmaceutical products, addressing various therapeutic fields, including central nervous, cardiovascular, respiratory, musculoskeletal, gastrointestinal systems, and anti-infectives.
Strategic Profile
Pro stress-test →As the leading company in the Saudi private market and the second leading generic in MENA, Tabuk Pharmaceuticals is delivering on its commitment to promoting well-being and consistently enhancing healthcare outcomes. The company is a fully owned subsidiary of Astra Industrial Group, a publicly traded company on the Saudi stock exchange. Its manufacturing sites produce over 2 billion base units annually to help maintain the health of millions of patients across 17 countries in the MENA region.
Competitive Landscape
Pro stress-test →Tabuk competes in the MENA generic and branded generic pharmaceutical market alongside international and regional players. Direct competitors include regional generic manufacturers and multinational pharma companies with presence in Saudi Arabia and the Gulf. The competitive positioning reflects consolidation around branded generics and therapeutic specialization, where Tabuk's scale and regional distribution network provide advantages against smaller pure-play generics and disadvantages against larger integrated multinationals in innovation velocity.
Industry Context
Tabuk Pharmaceuticals operates in Generic pharmaceuticals manufacturing and distribution.
Key facts
Founded: 1994 · Headquarters: Riyadh, Saudi Arabia · Employees: 2,400 · Revenue: $72M